Title
Injection of Hyaluronic Acid Versus Corticosteroid for Treatment of Trigger Finger
Ultrasound-Guided Injection of Hyaluronic Acid Versus Corticosteroid for Treatment of Trigger Finger: Randomized Controlled Study
Phase
Early Phase 1Lead Sponsor
Government of DubaiStudy Type
InterventionalStatus
Unknown statusIndication/Condition
Trigger FingerIntervention/Treatment
hyaluronic acid (20 mg/2 mL) Triamcinolone acetonide 10mg/mlStudy Participants
100The aim of the study is to compare the therapeutic effects of hyaluronic acid versus steroid injections in treating trigger fingers using ultrasound guidance
A prospective randomized controlled study designed to compare the outcomes of injecting patients with trigger finger with hyaluronic acid versus corticosteroid under ultrasound guidance
A1-Pulley infiltration for trigger finger
A1-Pulley infiltration for trigger finger
1mL of hyaluronic acid (20 mg/2 mL; Hyalgan, Fidia, Abano Terme, Italy) infiltration at A1-Pulley under ultrasound guidance after subcutaneous 2% lidocaine without epinephrine infiltration of the skin overlying the A1-pulley.
1 mL of Triamcinolone acetonide 10mg/ml infiltration at A1-Pulley under ultrasound guidance after subcutaneous 2% lidocaine without epinephrine infiltration of the skin overlying the A1 pulley.
Inclusion Criteria: Adult (>18 years) Patients with a clinical diagnosis of trigger finger grade 1-3 on the Quinnell grading scale and confirmed diagnosis by ultrasound. Exclusion Criteria: Quinnell's classification grade IV (contracture) Prior injection within 6 months Prior operation of the affected finger Presence of any contracture in the proximal interphalangeal or metacarpophalangeal joint, and History of diabetes, hypothyroidism, and Rheumatic or connective tissue disease Allergy to triamcinolone or hyaluronic acid Pregnancy Secondary triggering e.g. Trauma, infection Trigger finger symptoms duration >6 months